Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As
Klonalität:
Monoclonal
Klon-Bezeichnung:
[46E3]
Reinheit:
Protein A chromatography
Formulierung:
Purified
Antibody Type:
Monoclonal Antibody
Application Verdünnung:
ELISA detection: 0.01-0.05 µg/ml
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten